Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Approvals/HSA/AGELMIN TABLET 10 MG

Approved

THERAPEUTIC

AGELMIN TABLET 10 MG

KLEVA S.A. (GREECE)🇸🇬 Health Sciences Authority

Approval Date: Aug 20, 2003
Approval ID: 23a4cffd22af089b
Company: KLEVA S.A. (GREECE)
Type: Therapeutic

Approval Details

Approval Id: 23a4cffd22af089b
Drug Name: AGELMIN TABLET 10 MG
Product Name: AGELMIN TABLET 10 MG
Approval Number: SIN12396P
Approval Date: 2003-08-20
Registrant: PHARMAKOE PTE. LTD.
Licence Holder: PHARMAKOE PTE. LTD.
Drug Type: Therapeutic
Forensic Classification: PHARMACY ONLY MEDICINES
Dosage Form: TABLET, FILM COATED
Route Of Administration: ORAL
Atc Code: R06AE07
Atc Item Name: cetirizine
Pharma Manufacturer Name: PHARMAKOE PTE. LTD.

Active Ingredients

CETIRIZINE DIHCl

10 mg

CETIRIZINE DIHCL

10 MG

Approved

Quick Info

Agency

HSA

Country

🇸🇬

Approval Date

Aug 20, 2003

Approval ID

23a4cffd22af089b

Type

Therapeutic

Back to HSA Approvals

AGELMIN TABLET 10 MG - HSA Drug Approval Details